Preferential interactions of trehalose, L-arginine.HCl and sodium chloride with therapeutically relevant IgG1 monoclonal antibodies

References

• Ecker DM, Jones SD, Levine HL. The therapeutic monoclonal antibody market. mAbs. 2015;7:9-14. doi:10.4161/19420862.2015.989042. PMID:25529996
   PubMed Web of Science ®Google Scholar
• Adams GP, Weiner LM. Monoclonal antibody therapy of cancer. Nat Biotechnol. 2005;23:1147-57. doi:10.1035/nbt1137. PMID:16151408
   PubMed Web of Science ®Google Scholar
• Chan AC, Carter PJ. Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol. 2010;10:301-16. doi:10.1038/nri2761. PMID:20414204
   PubMed Web of Science ®Google Scholar
• Flego M, Ascione A, Cianfriglia M, Vella S. Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases. BMC Med. 2013;11:4. doi:10.1186/1741-7015-11-4. PMID:23289632
   PubMed Web of Science ®Google Scholar
• Stoner KL, Harder H, Fallowfield LJ, Jenkins VA. Intravenous versus subcutaneous drug administration. Which do patients prefer? A systematic review. Patient. 2015;8:145-53. doi:10.1007/s40271-014-0075-y
   Google Scholar
• Mathaes R, Koulov A, Joerg S, Mahler HC. Subcutaneous injection volume of biopharmaceuticals-pushing the boundaries. J Pharm Sci. 2016;105:2255-9. doi:10.1016/j.xphs.2016.05.029. PMID:27378678
   PubMed Web of Science ®Google Scholar
• Dani B, Platz R, Tzannis ST. High concentration formulation feasibility of human immunoglubulin G for subcutaneous administration. J Pharm Sci. 2007;96:1504-17. doi:10.1002/jps.20508. PMID:17387698
   PubMed Web of Science ®Google Scholar
• Shire SJ. Formulation and manufacturability of biologics. Curr Opin Biotechnol. 2009;20:708-14. doi:10.1016/j.copbio.2009.10.006. PMID:19880308
   PubMed Web of Science ®Google Scholar
• Tomar DS, Kumar S, Singh SK, Goswami S, Li L. Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high concentration drug product development. mAbs. 2016;8:216-28. doi:10.1080/19420862.2015.1128606. PMID:26736022
   PubMed Web of Science ®Google Scholar
• Chennamsetty N, Voynov V, Kayser V, Helk B, Trout BL. Design of therapeutic proteins with enhanced stability. Proc Natl Acad Sci U S A. 2009;106:11937-42. doi:10.1073/pnas.0904191106. PMID:19571001
   PubMed Web of Science ®Google Scholar
• Agrawal NJ, Helk B, Kumar S, Mody N, Sathish HA, Samra HS, Buck PM, Li L, Trout BL. Computational tool for the early screening of monoclonal antibodies for their viscosities. mAbs. 2016;8:43-8. doi:10.1080/19420862.2015.1099773. PMID:26399600
   PubMed Web of Science ®Google Scholar
• Courtois F, Schneider CP, Agrawal NJ, Trout BL. Rational design of biobetters with enhanced stability. J Pharm Sci. 2015;104:2433-40. doi:10.1002/jps.24520. PMID:26096711
   PubMed Web of Science ®Google Scholar
• Ohtake S, Kita Y, Arakawa T. Interactions of formulation excipients with proteins in solution and in the dried state. Adv Drug Deliv Rev. 2011;63:1053-73. doi:10.1016/j.addr.2011.06.011. PMID:21756953
   PubMed Web of Science ®Google Scholar
• Kamerzell TJ, Esfandiary R, Joshi SB, Middaugh CR, Volkin DB. Protein-excipient interactions: Mechanisms and biophysical characterization applied to protein formulation development. Adv Drug Deliv Rev. 2011;63:1118-59. doi:10.1016/j.addr.2011.07.006. PMID:21855584
   PubMed Web of Science ®Google Scholar
• Razinkov VI, Treuheit MJ, Becker GW. Accelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: Review of methods and tools. J Biomol Screen. 2015;20:468-83. doi:10.1177/1087057114565593. PMID:25576149
   PubMedGoogle Scholar
• He F, Woods CE, Becker GW, Narhi LO, Razinkov VI. High-throughput assessment of thermal and colloidal stability parameters for monoclonal antibody formulations. J Pharm Sci. 2011;100:5126-41. doi:10.1002/jps.22712. PMID:21789772
   PubMed Web of Science ®Google Scholar
• Philo JS, Arakawa T. Mechanisms of protein aggregation. Curr Pharm Biotechnol. 2009;10:348-51. doi:10.2174/138920109788488932. PMID:19519409
   PubMed Web of Science ®Google Scholar
• Esfandiary R, Parupudi A, Casas-Finet J, Gadre D, Sathish H. Mechanism of reversible self-association of a monoclonal antibody: Role of electrostatic and hydrophobic interactions. J Pharm Sci. 2015;104:577-86. doi:10.1002/jps.24237. PMID:25407315
   PubMed Web of Science ®Google Scholar
• Andrews JM, Roberts CJ. A Lumry-Eyring nucleated polymerization model of protein aggregation kinetics: 1. Aggregation with pre-equilibrated unfolding. J Phys Chem B. 2007;111:7897-913. doi:10.1021/jp070212j. PMID:17571872
   PubMed Web of Science ®Google Scholar
• Roberts CJ. Therapeutic protein aggregation: Mechanisms, design, and control. Trends Biotechnol. 2014;32:372-80. doi:10.1016/j.tibtech.2014.05.005. PMID:24908382
   PubMed Web of Science ®Google Scholar
• Timasheff SN. Control of protein stability and reactions by weakly interacting cosolvents: The simplicity of the complicated. Adv Protein Chem. 1998;51:355-432. doi:10.1016/S0065-3233(08)60656-7. PMID:9615174
   PubMedGoogle Scholar
• Timasheff SN. Protein-solvent preferential interactions, protein hydration, and the modulation of biochemical reactions by solvent components. Proc Natl Acad Sci U S A. 2002;99:9721-6. doi:10.1073/pnas.122225399. PMID:12097640
   PubMed Web of Science ®Google Scholar
• Timasheff SN. Thermodynamic binding and site occupancy in the light of the Schellman exchange concept. Biophys Chem. 2002;101:99-111. doi:10.1016/s0301-4622(02)00188-6. PMID:12487993
   PubMed Web of Science ®Google Scholar
• Schellman JA. Selective binding and solvent denaturation. Biopolymers. 1987;26:549-59. doi:10.1002/bip.360260408. PMID:3567326
   PubMed Web of Science ®Google Scholar
• Wyman J. Binding potential a neglected linkage concept. J Mol Biol. 1965;11:631-44. doi:10.1016/S0022-2836(65)80017-1. PMID:14267283
   PubMed Web of Science ®Google Scholar
• Hong J, Capp MW, Anderson CF, Saecker RM, Felitsky DJ, Anderson MW, Record MT. Preferential interactions of glycine betaine and of urea with DNA: Implications for DNA hydration and for effects of these solutes on DNA stability. Biochemistry. 2004;43:14744-58. doi:10.1021/bi049096q. PMID:15544345
   PubMed Web of Science ®Google Scholar
• Schneider CP, Trout BL. Investigation of cosolute-protein preferential interaction coefficients: New insight into the mechanism by which arginine inhibits aggregation. J Phys Chem B. 2009;113:2050-8. doi:10.1021/jp808042w. PMID:19199688
   PubMed Web of Science ®Google Scholar
• Arakawa T, Timasheff SN. Preferential interactions of proteins with salts in concentrated-solutions. Biochemistry. 1982;21:6545-52. doi:10.1021/bi00268a034. PMID:7150575
   PubMed Web of Science ®Google Scholar
• Xie GF, Timasheff SN. The thermodynamic mechanism of protein stabilization by trehalose. Biophys Chem. 1997;64:25-43. doi:10.1016/s0301-4622(96)02222-3. PMID:9127936
   PubMed Web of Science ®Google Scholar
• Courtenay ES, Capp MW, Record MT. Thermodynamics of interactions of urea and guanidinium salts with protein surface: Relationship between solute effects on protein processes and changes in water-accessible surface area. Protein Sci. 2001;10:2485-97 doi:10.1110/ps.ps.20801. PMID:11714916
   PubMed Web of Science ®Google Scholar
• Barnett GV, Razinkov VI, Kerwin BA, Blake S, Qi W, Curtis RA, Roberts CJ. Osmolyte effects on monoclonal antibody stability and concentration-dependent protein interactions with water and common osmolytes. J Phys Chem B. 2016;120:3318-30. doi:10.1021/acs.jpcb.6b00621. PMID:27007711
   PubMed Web of Science ®Google Scholar
• Hong J, Gierasch LM, Liu ZC. Its preferential interactions with biopolymers account for diverse observed effects of trehalose. Biophys J. 2015;109:144-53. doi:10.1016/j.bpj.2015.05.037. PMID:26153711
   PubMed Web of Science ®Google Scholar
• Shukla D, Trout BL. Interaction of arginine with proteins and the mechanism by which it inhibits aggregation. J Phys Chem B. 2010;114:13426-38. doi:10.1021/jp108399g. PMID:20925358
   PubMed Web of Science ®Google Scholar
• Saluja A, Fesinmeyer RM, Hogan S, Brems DN, Gokarn YR. Diffusion and sedimentation interaction parameters for measuring the second virial coefficient and their utility as predictors of protein aggregation. Biophys J. 2010;99:2657-65. doi:10.1016/j.bpj.2010.08.020. PMID:20959107
   PubMed Web of Science ®Google Scholar
• Connolly BD, Petry C, Yadav S, Demeule B, Ciaccio N, Moore JMR, Shire SJ, Gokarn YR. Weak interactions govern the viscosity of concentrated antibody solutions: High-throughput analysis using the diffusion interaction parameter. Biophys J. 2012;103:69-78. doi:10.1016/j.bpj.2012.04.047. PMID:22828333
   PubMed Web of Science ®Google Scholar
• Moussa EM, Panchal JP, Moorthy BS, Blum JS, Joubert MK, Narhi LO, Topp EM. Immunogenicity of therapeutic protein aggregates. J Pharm Sci. 2016;105:417-30. doi:10.1016/j.xphs.2015.11.002. PMID:26869409
   PubMed Web of Science ®Google Scholar
• Baynes BM, Trout BL. Rational design of solution additives for the prevention of protein aggregation. Biophys J. 2004;87:1631-9. doi:10.1529/biophysj.104.042473. PMID:15345542
   PubMed Web of Science ®Google Scholar
• Yadav S, Shire SJ, Kalonia DS. Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies. J Pharm Sci. 2010;99:4812-29. doi:10.1002/jps.22190. PMID:20821382
   PubMed Web of Science ®Google Scholar
• Chari R, Jerath K, Badkar AV, Kalonia DS. Long- and short-range electrostatic interactions affect the rheology of highly concentrated antibody solutions. Pharm Res. 2009;26:2607-18. doi:10.1007/s11095-009-9975-2. PMID:19795191
   PubMed Web of Science ®Google Scholar
• Buck PM, Chaudhri A, Kumar S, Singh SK. Highly viscous antibody solutions are a consequence of network formation caused by domain-domain electrostatic complementarities: Insights from coarse-grained simulations. Mol Pharm. 2015;12:127-39. doi:10.1021/mp500485w. PMID:25383990
   PubMed Web of Science ®Google Scholar
• Kanai S, Liu J, Patapoff TW, Shire SJ. Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity. J Pharm Sci. 2008;97:4219-27. doi:10.1002/jps.21322. PMID:18240303
   PubMed Web of Science ®Google Scholar
• Du W, Klibanov AM. Hydrophobic salts markedly diminish viscosity of concentrated protein solutions. Biotechnol Bioeng. 2011;108:632-6. doi:10.1002/bit.22983. PMID:21246510
   PubMed Web of Science ®Google Scholar
• Shah D, Li JG, Shaikh AR, Rajagopalan R. Arginine-aromatic interactions and their effects on arginine-induced solubilization of aromatic solutes and suppression of protein aggregation. Biotechnol Prog. 2012;28:223-31. doi:10.1002/btpr.710. PMID:21948347
   PubMed Web of Science ®Google Scholar
• Arakawa T, Timasheff SN. Abnormal solubility behavior of beta-lactoglobulin - salting-in by glycine and NaCl. Biochemistry. 1987;26:5147-53. doi:10.1021/bi00390a038. PMID:3663650
   PubMed Web of Science ®Google Scholar
• Gokarn YR, Fesinmeyer RM, Saluja A, Razinkov V, Chase SF, Laue TM, Brems DN. Effective charge measurements reveal selective and preferential accumulation of anions, but not cations, at the protein surface in dilute salt solutions. Protein Sci. 2011;20:580-7. doi:10.1002/pro.591. PMID:21432935
   PubMed Web of Science ®Google Scholar
• Roberts D, Keeling R, Tracka M, van der Walle CF, Uddin S, Warwicker J, Curtis R. Specific ion and buffer effects on protein-protein interactions of a monoclonal antibody. Mol Pharm. 2015;12:179-93. doi:10.1021/mp500533c. PMID:25389571
   PubMed Web of Science ®Google Scholar
• Schmit JD, He F, Mishra S, Ketchem RR, Woods CE, Kerwin BA. Entanglement Model of Antibody Viscosity. Journal of Physical Chemistry B 2014;118:5044-9. doi:10.1021/jp500434b
   PubMed Web of Science ®Google Scholar
• Li L, Kumar S, Buck PM, Burns C, Lavoie J, Singh SK, Warne NW, Nichols P, Luksha N, Boardman D. Concentration dependent viscosity of monoclonal antibody solutions: Explaining experimental behavior in terms of molecular properties. Pharm Res. 2014;31:3161-78. doi:10.1007/s11095-014-1409-0
   PubMed Web of Science ®Google Scholar
• Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Iype L, Jain S, Fagan P, Marvin J, et al. The protein data bank. Acta Crystallogr Sect D-Biol Crystallogr. 2002;58:899-907. doi:10.1107/s0907444902003451
   PubMed Web of Science ®Google Scholar
• Sircar A, Kim ET, Gray JJ. Rosetta antibody: Antibody variable region homology modeling server. Nucleic Acids Res. 2009;37:W474-W9. doi:10.1093/nar/gkp387. PMID:19458157
   PubMed Web of Science ®Google Scholar
• Brandt JP, Patapoff TW, Aragon SR. Construction, MD simulation, and hydrodynamic validation of an all-atom model of a monoclonal IgG antibody. Biophys J. 2010;99:905-13. doi:10.1016/j.bpj.2010.05.003. PMID:20682269
   PubMed Web of Science ®Google Scholar
• Padlan EA. Anatomy of the antibody molecule. Mol Immunol. 1994;31:169-217. doi:10.1016/0161-5890(94)90001-9. PMID:8114766
   PubMed Web of Science ®Google Scholar
• MacKerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B. 1998;102:3586-616. doi:10.1021/jp973084f. PMID:24889800
   PubMed Web of Science ®Google Scholar
• Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926-35. doi:10.1063/1.445869
   Web of Science ®Google Scholar
• Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kale L, Schulten K. Scalable molecular dynamics with NAMD. J Comput Chem. 2005;26:1781-802. doi:10.1002/jcc.20289 PMID:16222654
   PubMed Web of Science ®Google Scholar
• Dolinsky TJ, Czodrowski P, Li H, Nielsen JE, Jensen JH, Klebe G, Baker NA. PDB2PQR: Expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res. 2007;35:W522-W5. doi:10.1093/nar/gkm276. PMID:17488841
   PubMed Web of Science ®Google Scholar
• Ewoldt RH, Johnston MT, Caretta LM. Experimental challenges of shear rheology: How to avoid bad data. In Spagnolie SE, ed. Complex fluids in biological systems: Experiment, theory, and computation. New York: Springer; 2015. 207-41
   Google Scholar